Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

A Methyltransferase-Defective Vesicular Stomatitis Virus-Based SARS-CoV-2 Vaccine Candidate Provides Complete Protection against SARS-CoV-2 Infection in Hamsters

Journal of Virology(2021)10.1128/jvi.00592-21Source: DataRank Database

A Methyltransferase-Defective Vesicular Stomatitis Virus-Based SARS-CoV-2 Vaccine Candidate Provides Complete Protection against SARS-CoV-2 Infection in Hamsters is a research paper published in Journal of Virology (2021). On theSindex it has a DataRank of 0.685. It has been cited 23 times, with 19 citing works in its 1-hop citation network.

N/A

0.685DataRank · unranked

Scored on demand from live citation data

Open Access23 citations · 19 citing works in its network

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (11 grants)Impact (FWCI 1.36)OA: greenTopics (65)IDs (PubMed, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 70%Citation Network 30%

Base Score Contribution

0.477

From this paper's citation signal

Citation Network Contribution

0.208

From 8 citing papers with measurable signal

Learn more about DataRank methodology →

Top 5 citers driving the network score

Ranked by each citer's contribution to N(p) — log1p(C_q) divided by its reference count — out of 19 citers.

MVA-CoV2-S Vaccine Candidate Neutralizes Distinct Variants of Concern and Protects Against SARS-CoV-2 Infection in Hamsters
Frontiers in Immunology202226 citations43 referencesContributes 0.077
Viral Vector Vaccine Development and Application during the COVID-19 Pandemic
Microorganisms2022107 citations79 referencesContributes 0.059
Preclinical immunogenicity and efficacy of a candidate COVID-19 vaccine based on a vesicular stomatitis virus-SARS-CoV-2 chimera
EBioMedicine202222 citations107 referencesContributes 0.029
Pseudotyped Vesicular Stomatitis Virus-Severe Acute Respiratory Syndrome-Coronavirus-2 Spike for the Study of Variants, Vaccines, and Therapeutics Against Coronavirus Disease 2019
Frontiers in Microbiology202233 citations123 referencesContributes 0.029
Self-replicating vehicles based on negative strand RNA viruses
Cancer Gene Therapy202217 citations153 referencesContributes 0.019

Authors (22)

Yuexiu Zhang ORCID,Piyush Dravid ORCID,Anzhong Li,Cong Zeng ORCID,Mahesh KC

Live enrichment

PubMed:34379509 OpenAlex:https://openalex.org/W3188013878

HHS | National Institutes of Health

Grant: AI090060

HHS | National Institutes of Health

Grant: HG008935

HHS | National Institutes of Health

Grant: AI112524

HHS | National Institutes of Health

Grant: AI42733

National Institutes of Health

Grant: 1R01AI112381-01

IFITM-mediated Inhibition of HIV Infection and Viral Countermeasures

National Institutes of Health

Grant: 5R01AI137567-05

Host response and liver disease in a hepatitis C-like virus rat model

National Institutes of Health

Grant: 5R01AI090060-02

Messenger RNA Capping and Methylation in Pneumoviruses

National Institutes of Health

Grant: 3RM1HG008935-05S1

Center for dynamic RNA epitranscriptomes - Covid 19 Supplement Version 2

National Institutes of Health

Grant: 5R01AI150473-04

TIM-mediated Inhibition of HIV Release: Cooperation with SERINC and Antagonism by Nef

National Institutes of Health

Grant: 5R01AI151175-03

Immune correlates of protection against hepacivirus persistence.

National Institutes of Health

Grant: 5P01AI112524-02

Live Attenuated RSV Vaccine with Optimized Safety and Immunogenicity

FWCI

1.36

Citation Percentile

0.8%

Citation Trend

2022

2023

2024

2026

greenLicense: https://doi.org/10.1128/ASMCopyrightv2

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8475528

publisherhttps://journals.asm.org/doi/pdf/10.1128/JVI.00592-21

journalhttps://doi.org/10.1128/jvi.00592-21

repositoryhttps://pubmed.ncbi.nlm.nih.gov/34379509

Fields of Study

SARS-CoV-2 and COVID-19 ResearchViral Infections and Outbreaks ResearchVirology and Viral Diseases0301 basic medicine03 medical and health sciences

MeSH Terms

Immunogenicity, VaccineProtein DomainsCytokine Release SyndromeCOVID-19SARS-CoV-2COVID-19 VaccinesAnimalsAntibodies, ViralBrainCell LineHumansLungMesocricetusMethyltransferasesDNA-Directed RNA PolymerasesVaccines, SyntheticVesicular stomatitis Indiana virusViral ProteinsVirus ReplicationTh1 CellsMiceAntibodies, NeutralizingSpike Glycoprotein, Coronavirus

Keywords

VirologyBiologyVesicular stomatitis virusCoronavirusVirusImmune systemVaccinationAntibodyImmunologyViral sheddingRecombinant DNAMedicineInfectious disease (medical specialty)Coronavirus disease 2019 (COVID-19)DiseaseGeneVaccines, SyntheticCOVID-19 VaccinesMesocricetusSARS-CoV-2BrainCOVID-19DNA-Directed RNA PolymerasesMethyltransferasesTh1 CellsAntibodies, ViralAntibodies, NeutralizingCell LineMiceImmunogenicity, VaccineProtein DomainsVaccines and Antiviral AgentsSpike Glycoprotein, CoronavirusAnimalsHumansCytokine Release SyndromeLung

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being